|1.||Yodoi, Junji: 8 articles (01/2012 - 09/2004)|
|2.||Masutani, Hiroshi: 7 articles (01/2012 - 09/2004)|
|3.||Nakamura, Hajime: 4 articles (09/2010 - 01/2006)|
|4.||Yoshihara, Eiji: 2 articles (01/2012 - 03/2009)|
|5.||Oka, Shin-Ichi: 2 articles (10/2009 - 09/2004)|
|6.||Oka, Shin-ichi: 2 articles (03/2009 - 01/2006)|
|7.||Liu, Wenrui: 2 articles (03/2009 - 01/2006)|
|8.||Masaki, So: 1 article (01/2012)|
|9.||Yodoi, J: 1 article (03/2011)|
|10.||Chen, Z: 1 article (03/2011)|
|1.||Chronic Hepatitis C
06/01/2006 - "The aim of this study was to evaluate the clinical significance of the expression of TRX and thioredoxin-binding protein-2 (TBP-2), which is a negative regulator of TRX function, in the liver of patients with chronic hepatitis C and the relationship of this to the efficacy of interferon (IFN) treatment. "
06/01/2006 - "Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy."
03/01/2011 - "The transformation associates the loss of thioredoxin-binding protein-2 (TBP-2), a tumor suppressor and regulator of lipid metabolism. "
01/01/2012 - "Thioredoxin binding protein-2 (TBP-2, also called Txnip or VDUP1) is downregulated in various types of human cancer, and its deficiency results in the earlier onset of cancer. "
09/01/2010 - "Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2."
09/15/2007 - "Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome."
09/03/2002 - "The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin."
|3.||Hypoglycemia (Reactive Hypoglycemia)
02/01/2010 - "Thioredoxin binding protein-2 inhibits excessive fetal hypoglycemia during maternal starvation by suppressing insulin secretion in mice."
03/01/2009 - "The targeted disruption of the thioredoxin binding protein-2 (TBP-2)/thioredoxin-interacting protein (Txnip)/VDUP1 gene in mice results in lethality with hypertriglyceridemia and hypoglycemia during fasting. "
|3.||tributyl phosphate (TBP)
|4.||Histone Deacetylase Inhibitors
|6.||Proteins (Proteins, Gene)
|9.||Choline (Choline Chloride)
|10.||Cholecalciferol (Vitamin D3)